{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:38:49Z","timestamp":1781001529973,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T00:00:00Z","timestamp":1519689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013385","name":"National Science and Technology Program during the Twelfth Five-year Plan Period","doi-asserted-by":"publisher","award":["2015BAD1101"],"award-info":[{"award-number":["2015BAD1101"]}],"id":[{"id":"10.13039\/501100013385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010203","name":"Agriculture Research System of China","doi-asserted-by":"publisher","award":["CAR-38"],"award-info":[{"award-number":["CAR-38"]}],"id":[{"id":"10.13039\/501100010203","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ijpddr.2018.02.006","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T15:12:23Z","timestamp":1519917143000},"page":"238-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo"],"prefix":"10.1016","volume":"8","author":[{"given":"Hongfei","family":"Si","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xukun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuzheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2018.02.006_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004790","article-title":"Performance testing of PCR assay in blood samples for the diagnosis of toxoplasmic encephalitis in AIDS patients from the French departments of America and genetic diversity of Toxoplasma gondii: a prospective and multicentric study","volume":"10","author":"Ajzenberg","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib30","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/AAC.5.6.647","article-title":"Effect of clindamycin on acute and chronic toxoplasmosis in mice","volume":"5","author":"Araujo","year":"1974","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.biopha.2016.11.047","article-title":"Cytotoxicity of trans-chalcone and licochalcone A against breast cancer cells is due to apoptosis induction and cell cycle arrest","volume":"85","author":"Bortolotto","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.exppara.2013.10.001","article-title":"Toxoplasma gondii infection: what is the real situation?","volume":"135","author":"Chemoh","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib4","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1128\/AAC.37.12.2550","article-title":"Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania","volume":"37","author":"Chen","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib5","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1128\/AAC.38.7.1470","article-title":"Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection","volume":"38","author":"Chen","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jep.2008.05.023","article-title":"Anti-Toxoplasma gondii activity of GAS in vitro","volume":"118","author":"Chen","year":"2008","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3892\/ijo.2014.2461","article-title":"Licochalcone A, a natural chalconoid isolated from Glycyrrhiza inflata root, induces apoptosis via Sp1 and Sp1 regulatory proteins in oral squamous cell carcinoma","volume":"45","author":"Cho","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijantimicag.2008.04.012","article-title":"Anti-Toxoplasma gondii RH strain activity of herbal extracts used in traditional medicine","volume":"32","author":"Choi","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijpddr.2018.02.006_bib9","first-page":"361","article-title":"Anti-inflammatory activity of licochalcone A isolated from Glycyrrhiza inflata","volume":"63","author":"Cui","year":"2008","journal-title":"J. Biosci."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-116-1-33","article-title":"Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group","volume":"116","author":"Dannemann","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib11","first-page":"146","article-title":"Toxoplasmosis in pregnancy and its transmission to the fetus","volume":"50","author":"Desmonts","year":"1974","journal-title":"Bull. N. Y. Acad. Med."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib12","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.ijpara.2008.03.007","article-title":"Toxoplasma gondii infection in humans and animals in the United States","volume":"38","author":"Dubey","year":"2008","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00281-012-0339-3","article-title":"Immune response and immunopathology during toxoplasmosis","volume":"34","author":"Dupont","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib14","first-page":"483","article-title":"Synergistic effect of sulfadiazine and daraprim against experimental toxoplasmosis in the mouse","volume":"3","author":"Eyles","year":"1953","journal-title":"Antibiot. Chemother."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0140-6736(92)90132-M","article-title":"Azithromycin for cerebral toxoplasmosis","volume":"339","author":"Farthing","year":"1992","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijpddr.2018.02.006_bib16","first-page":"957","article-title":"Spiramycin therapy of experimental toxoplasmosis in mice","volume":"66","author":"Garin","year":"1958","journal-title":"Presse Med."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2165\/00003495-199448020-00005","article-title":"Management of toxoplasmosis","volume":"48","author":"Georgiev","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.ijpddr.2018.02.006_bib18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1056\/NEJM199402243300817","article-title":"Treatment of presumed cerebral toxoplasmosis with azithromycin","volume":"330","author":"Godofsky","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0020-7519(99)00170-8","article-title":"Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR1","volume":"30","author":"Homan","year":"2000","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00109-010-0625-2","article-title":"Antitumor and antimetastatic effects of licochalcone A in mouse models","volume":"88","author":"Kim","year":"2010","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0140-6736(92)92172-C","article-title":"Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS","volume":"340","author":"Kovacs","year":"1992","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijpddr.2018.02.006_bib23","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.ejmech.2007.10.007","article-title":"Functionalized chalcones with basic functionalities have antibacterial activity against drug sensitive Staphylococcus aureus","volume":"43","author":"Liu","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/clinids\/15.2.211","article-title":"Toxoplasmic encephalitis in AIDS","volume":"15","author":"Luft","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4269\/ajtmh.1973.22.14","article-title":"The effect of two chlorinated lincomycin analogues against acute toxoplasmosis in mice","volume":"22","author":"Mcmaster","year":"1973","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib26","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijpddr.2018.02.006_bib27","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1128\/AAC.02009-15","article-title":"Clinically available medicines demonstrating anti-toxoplasma activity","volume":"59","author":"Neville","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/clinids\/22.1.175","article-title":"A clarithromycin-induced myasthenic syndrome","volume":"22","author":"Pijpers","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib29","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/clinids\/20.4.1076","article-title":"Breakthrough cerebral toxoplasmosis in patients with AIDS who are being treated with clarithromycin","volume":"20","author":"Raffi","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3181\/00379727-51-13809","article-title":"Therapeutic effectiveness of certain sulfonamides on infection by an intracellular protozoon (toxoplasma)","volume":"51","author":"Sabin","year":"1942","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2174\/1574891X10666150410120321","article-title":"Anti-Toxoplasma activity of natural products: a review","volume":"9","author":"Sepulveda-Arias","year":"2014","journal-title":"Recent Pat. Anti-Infect. Drug Discov."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.exppara.2016.03.021","article-title":"Effects of (+)-Usnic acid and (+)-Usnic acid-liposome on toxoplasma gondii","volume":"166","author":"Si","year":"2016","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0140-6736(93)90107-R","article-title":"Azithromycin for cerebral toxoplasmosis in AIDS","volume":"341","author":"Wynn","year":"1993","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijpddr.2018.02.006_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2010.12.016","article-title":"Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis","volume":"302","author":"Xiao","year":"2011","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib36","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1128\/AAC.39.12.2742","article-title":"The antileishmanial agent licochalcone A interferes with the function of parasite mitochondria","volume":"39","author":"Zhai","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.02.006_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.exppara.2016.03.020","article-title":"Antiparasitic effects of oxymatrine and matrine against Toxoplasma gondii in vitro and in vivo","volume":"165","author":"Zhang","year":"2016","journal-title":"Exp. Parasitol."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320717301112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320717301112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:49:27Z","timestamp":1761922167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320717301112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S2211320717301112"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2018.02.006","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2018.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}